000			01398 a2200373 4500
005			20250515223446.0
264		0	_c20101223
008			201012s 0 0 eng d
022			_a1878-5492
024	7		_a10.1016/j.trim.2010.05.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchildberg, Frank A
245	0	0	_aImproved transplantation outcome by epigenetic changes. _h[electronic resource]
260			_bTransplant immunology _cJul 2010
300			_a104-10 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aDNA Modification Methylases _xantagonists & inhibitors
650	0	4	_aEpigenesis, Genetic _xdrug effects
650	0	4	_aGraft Rejection _xdrug therapy
650	0	4	_aHistone Deacetylase Inhibitors _xtherapeutic use
650	0	4	_aHistone Deacetylases _xmetabolism
650	0	4	_aHumans
650	0	4	_aImmunomodulation _xdrug effects
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aOrgan Transplantation
650	0	4	_aOxygen _xadministration & dosage
650	0	4	_aTransplantation Immunology
700	1		_aHagmann, Cristina A
700	1		_aBöhnert, Volker
700	1		_aTolba, René H
773	0		_tTransplant immunology _gvol. 23 _gno. 3 _gp. 104-10
856	4	0	_uhttps://doi.org/10.1016/j.trim.2010.05.001 _zAvailable from publisher's website
999			_c19825783 _d19825783